SELESYN

This brand name is authorized in Hong Kong, Ireland, South Africa

Active ingredients

The drug SELESYN contains one active pharmaceutical ingredient (API):

1 Sodium selenite
UNII HIW548RQ3W - SODIUM SELENITE

Selenium is an essential trace element. In human, selenium compounds are glutathione peroxidase and a selenium protein P found in the plasma. Deficiency of selenium has been associated with an endemic form of cardiomyopathy, Keshan disease and with Kaschin-Beck disease, an endemic osteoarthropathy which causes a severe deformity of the joints.

Read about Sodium selenite

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SELESYN Oral solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
SELESYN Solution for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A12CE02 Sodium selenite A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CE Selenium
Discover more medicines within A12CE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HK Department of Health Drug Office Identifier(s): 63846, 63847, 63948
Country: ZA Health Products Regulatory Authority Identifier(s): 38/24/0441, A38/32.2/0442

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.